II
PTGX icon

Inspire Investing’s Protagonist Therapeutics PTGX Stock Holding History

Inspire Investing’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,938
Closed -$461K – 1159
2025
Q3 		$461K Sell
6,938
-346
-5% -$19.7K 0.04% 369
2025
Q2 		$403K Sell
7,284
-14,550
-67% -$698K 0.04% 326
2025
Q1 		$1.06M Buy
21,834
+11,279
+107% +$473K 0.13% 180
2024
Q4 		$407K Sell
10,555
-25,959
-71% -$1.13M 0.05% 365
2024
Q3 		$1.64M Buy
36,514
+26,280
+257% +$1.06M 0.17% 128
2024
Q2 		$355K Sell
10,234
-2,106
-17% -$61.7K 0.04% 419
2024
Q1 		$357K Sell
12,340
-4,442
-26% -$121K 0.04% 701
2023
Q4 		$385K Sell
16,782
-1,828
-10% -$32K 0.04% 488
2023
Q3 		$310K Buy
+18,610
New +$361K 0.04% 423

Other funds holding PTGX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return